Where does HWEL stock trade?

Healthwell Acquisition Corp. I (HWEL) is listed on NASDAQ.

What sector and industry is HWEL in?

Healthwell Acquisition Corp. I operates in the Finance sector, Blank Checks industry.

When did Healthwell Acquisition Corp. I go public?

Healthwell Acquisition Corp. I (HWEL) completed its IPO in 2021.

What companies are similar to HWEL?

Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare HWEL side-by-side with any of them on Quantisnow.

How can I track HWEL on Quantisnow?

Quantisnow aggregates Healthwell Acquisition Corp. I's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HWEL to receive live email and push alerts on every new disclosure.

HWEL

NASDAQ

Healthwell Acquisition Corp. I

SectorFinanceIndustryBlank ChecksIPO2021

$10.43-0.05 (-0.48%)

News25/Ratings0

Latest news

25 items

847d13D/G
SEC Form SC 13G/A filed by Healthwell Acquisition Corp. I (Amendment)
SC 13G/A - Healthwell Acquisition Corp. I (0001845013) (Subject)
865d13D/G
SEC Form SC 13G/A filed by Healthwell Acquisition Corp. I (Amendment)
SC 13G/A - Healthwell Acquisition Corp. I (0001845013) (Subject)
880d13D/G
SEC Form SC 13G/A filed by Healthwell Acquisition Corp. I (Amendment)
SC 13G/A - Healthwell Acquisition Corp. I (0001845013) (Subject)
903dSEC
SEC Form 15-12G filed by Healthwell Acquisition Corp. I
15-12G - Healthwell Acquisition Corp. I (0001845013) (Filer)
917dSEC
SEC Form 25-NSE filed by Healthwell Acquisition Corp. I
25-NSE - Healthwell Acquisition Corp. I (0001845013) (Subject)
922dSEC
Healthwell Acquisition Corp. I filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (Amendment)
8-K/A - Healthwell Acquisition Corp. I (0001845013) (Filer)
934dSEC
Healthwell Acquisition Corp. I filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Healthwell Acquisition Corp. I (0001845013) (Filer)
932dNEWS
Healthwell Acquisition Corp. I Announces Cancellation Of Special Stockholder Meeting And Its Intention To Liquidate; Estimated Redemption Price Of Approximately $10.50 Per Share
Healthwell Acquisition Corp. I ("Healthwell") (NASDAQ:HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been cancelled, and that it has withdrawn from consideration by Healthwell's stockholders the proposals set forth in Heatlhwell's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on November 13, 2023 and (ii) it intends instead to liquidate.The board of directors of Healthwell (the "Board") has determined to (i) cease all operations except for the purpose of winding up as soon as practicable, (ii) as promptly as reasonably possible redeem the shares
934dPR
Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate
Healthwell Acquisition Corp. I ("Healthwell") (NASDAQ:HWEL) announced today that (i) its previously announced special meeting of stockholders that was scheduled for December 4, 2023 has been cancelled, and that it has withdrawn from consideration by Healthwell's stockholders the proposals set forth in Heatlhwell's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on November 13, 2023 and (ii) it intends instead to liquidate. The board of directors of Healthwell (the "Board") has determined to (i) cease all operations except for the purpose of winding up as soon as practicable, (ii) as promptly as reasonably possible redeem the sh
938dSEC
SEC Form DEF 14A filed by Healthwell Acquisition Corp. I
DEF 14A - Healthwell Acquisition Corp. I (0001845013) (Filer)
945dSEC
SEC Form 425 filed by Healthwell Acquisition Corp. I
425 - Healthwell Acquisition Corp. I (0001845013) (Subject)
945dSEC
Healthwell Acquisition Corp. I filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
8-K - Healthwell Acquisition Corp. I (0001845013) (Filer)
948dPR
Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.
Healthwell Acquisition Corp. I ("Healthwell") (NASDAQ:HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. ("Starton") was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combination. About Healthwell Healthwell is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
948dPR
Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I
Starton Therapeutics Inc. ("Starton" or "the Company"), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified Healthwell Acquisition Corp. I (NASDAQ:HWEL) ("Healthwell") today that the Company had elected to terminate the business combination agreement among Starton, Healthwell and the other parties thereto dated as of April 27, 2023, as amended (the "Combination Agreement"), effective immediately. The conditions to the closing of the initial business combination and subsequent amendments were not satisfied or waived by the outside date of November 3 2023 (the "Termination"). As a
950dSEC
SEC Form PRE 14A filed by Healthwell Acquisition Corp. I
PRE 14A - Healthwell Acquisition Corp. I (0001845013) (Filer)
959dSEC
SEC Form 425 filed by Healthwell Acquisition Corp. I
425 - Healthwell Acquisition Corp. I (0001845013) (Subject)
959dSEC
Healthwell Acquisition Corp. I filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Healthwell Acquisition Corp. I (0001845013) (Filer)
959dNEWS
Healthwell Acquisition Postpones Special Meeting For Business Combination With Starton Therapeutics
Healthwell Acquisition Has postponed until further announcement the date of the special meeting of the Company's stockholders to approve its proposed business combination with Starton Therapeutics, Inc. ("Starton") and related transactions that had been scheduled for 10:00 a.m. Eastern Time on October 25, 2023.
959dPR
Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions
Healthwell Acquisition Corp. I ("Healthwell," "HWEL" or the "Company") (NASDAQ:HWEL) announced today that it has postponed until further announcement the date of the special meeting of the Company's stockholders (the "Meeting") to approve its proposed business combination with Starton Therapeutics, Inc. ("Starton") and related transactions that had been scheduled for 10:00 a.m. Eastern Time on October 25, 2023. At the Meeting, the stockholders will vote on the proposals set forth in Healthwell's proxy statement/prospectus dated October 2, 2023 and filed with the Securities and Exchange Commission to approve the business combination with Starton and related proposals described therein (colle
966dSEC
SEC Form 425 filed by Healthwell Acquisition Corp. I
425 - Healthwell Acquisition Corp. I (0001845013) (Subject)
966dSEC
SEC Form 8-K filed by Healthwell Acquisition Corp. I
8-K - Healthwell Acquisition Corp. I (0001845013) (Filer)
966dPR
Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions
Healthwell Acquisition Corp. I ("Healthwell," "HWEL" or the "Company") (NASDAQ:HWEL) announced today that it has postponed the date of the special meeting of the Company's stockholders (the "Meeting") to approve its proposed business combination with Starton Therapeutics, Inc. ("Starton") and related transactions from the originally scheduled date of October 19, 2023. The new Meeting time and date will be 10:00 a.m. Eastern Time on October 25, 2023 and will be held virtually. At the Meeting, the stockholders will vote on the proposals set forth in Healthwell's proxy statement/prospectus dated October 2, 2023 and filed with the Securities and Exchange Commission to approve the business combi
978dNEWS
Healthwell Acquisition Corp. I Combination Partner Starton Therapeutics Doses First Patient In STAR-LLD Lenalidomide Phase 1b Clinical Trial In Multiple Myeloma
978dPR
Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
Dosing comes three weeks after the first site opened Full enrollment of six patients is expected to take 10 months, conducted in up to three clinical sites Multiple readings for safety and efficacy are expected during the next 6 to 18 months Starton Therapeutics Inc. ("Starton" or "the Company"), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced the dosing of the first patient in the STAR-LLD Phase 1b clinical trial, which will assess the safety, efficacy and pharmacokinetics of continuous subcutaneous administration of low-dose lenalidomide (STAR-LLD) for the treatment of multiple m
980dSEC
SEC Form DEFM14A filed by Healthwell Acquisition Corp. I
DEFM14A - Healthwell Acquisition Corp. I (0001845013) (Filer)

HWEL FAQ

5 questions

Where does HWEL stock trade?
Healthwell Acquisition Corp. I (HWEL) is listed on NASDAQ.
What sector and industry is HWEL in?
Healthwell Acquisition Corp. I operates in the Finance sector, Blank Checks industry.
When did Healthwell Acquisition Corp. I go public?
Healthwell Acquisition Corp. I (HWEL) completed its IPO in 2021.
What companies are similar to HWEL?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare HWEL side-by-side with any of them on Quantisnow.
How can I track HWEL on Quantisnow?
Quantisnow aggregates Healthwell Acquisition Corp. I's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HWEL to receive live email and push alerts on every new disclosure.